# OnCo record dorocubicel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dorocubicel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dorocubicel" ;
  schema:name "Dorocubicel (UM171-expanded cord blood)"@en ;
  schema:alternateName "UM171 cell therapy"@en, "ECT-001"@en, "Zemcelpro" ;
  schema:description "Zemcelpro is a laboratory-expanded umbilical cord blood transplant for adults with blood cancers who need a donor stem cell transplant but have no suitable matched donor; expanding the cells lets a single small cord blood unit be enough."@en ;
  schema:url <https://onco.cc/drugs/dorocubicel/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cord_blood> ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/zemcelpro> ;
  onco:status "approved" ;
  onco:tag "ema-list" ;
  onco:modality "Allogeneic expanded cord blood cell therapy (ATMP)" ;
  onco:approval "EU 2025: Adults with haematological malignancies requiring allogeneic HSCT after myeloablative conditioning with no other suitable donor cells" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/mds/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/allogeneic-cell-therapy/> ;
  onco:companies <https://onco.cc/companies/excellthera/> .